Marketing News & Digital Marketing Strategy

Sagefrog Hired by Penn Pharma

Editorial TeamBy Editorial Team1 min read
Sagefrog Hired by Penn Pharma
Share
Sagefrog Marketing Group everything-pr

Sagefrog Marketing Group, LLC, has been hired by Penn Pharma, a pharmaceutical company, to serve as their agency of record. The marketing company will be doing what they do best, focusing on public relations, communications and marketing or advertising.

"Sagefrog was chosen after a rigorous vetting process," said Paul N. Wituschek, Global Sales & Marketing Director at Penn Pharma. "We look forward to a strategic, productive relationship that will strengthen our marketing and visibility in North America." Penn Pharma is a company that strives to provide affordable and economical pharmaceutical development to healthcare companies. They also offer custom services in manufacturing. The company serves clients around the world with well established customer bases in Japan, Europe and North America. At the moment, the company is focusing on improving their visibility and branding within Canada and the U.S., which is where Sagefrog comes in. "We are delighted to be named Agency of Record for Penn Pharma. We are impressed with them as a company and look forward to helping them grow their business," said Mark Schmukler, Managing Partner, Sagefrog. Sagefrog works with companies based in Philadelphia and New Jersey and provides marketing and PR services. They specialize in specific industries, namely business, health and technology, so they have the experience necessary to promote Penn Pharma. With Sagefrog's help, Penn Pharma hopes to establish a firm customer base and continue to grow in North America.
Editorial Team
Written by
Editorial Team

The Everything-PR Editorial Team produces reporting, research, and analysis across thirty verticals — communications, reputation, AI visibility, public affairs, media systems, and digital discovery in the answer-engine era. Publishing since 2009.

Other news

See all

Never Miss a Headline

Daily PR headlines, weekly long-form analysis, and our proprietary research drops — straight to your inbox.